Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

FBTBX Fidelity Advisor® Biotechnology B

  • Fund
  • FBTBX
  • Price as of: N/A
  • N/A N/A N/A
  • Category
  • Health & Biotech Equities
  • Fund Company
  • N/A

FBTBX - Profile

Vitals

  • YTD Return N/A
  • 3 Yr Annualized Return 13.3%
  • 5 Yr Annualized Return 20.5%
  • Net Assets $2.83 B
  • Holdings in Top 10 47.3%

52 WEEK LOW AND HIGH

N/A
N/A
N/A

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.83%

SALES FEES

  • Front Load N/A
  • Deferred Load 5.00%

BROKERAGE FEES

  • Turnover 26.00%

TRADING FEES

  • Max Redemption Fee 0.75%

Min Investment

Closed to new investors as of Sep 01, 2010

STANDARD (TAXABLE)

$2,500

IRA

$500

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return N/A
  • 3 Yr Annualized Total Return 12.5%
  • 5 Yr Annualized Total Return 20.3%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio -1.53%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name Fidelity Advisor® Biotechnology Fund
  • Fund Family Name N/A
  • Inception Date Dec 27, 2000
  • Shares Outstanding N/A
  • Share Class B
  • Currency USD
  • Domiciled Country United States

Fund Description

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

FBTBX - Performance

Return Ranking - Trailing

Period FBTBX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -3.0% 27.4% N/A
1 Yr -25.8% -24.9% 8.1% N/A
3 Yr 13.3%* -17.8% 22.4% N/A
5 Yr 20.5%* -11.9% 14.2% N/A
10 Yr 13.3%* -1.8% 15.2% N/A

* Annualized


Return Ranking - Calendar

Period FBTBX Return Category Return Low Category Return High Rank in Category (%)
2018 N/A -25.3% 7.7% N/A
2017 N/A -10.8% 43.9% N/A
2016 N/A -29.8% 2.6% N/A
2015 N/A -20.4% 13.8% N/A
2014 N/A -5.8% 31.5% N/A

Total Return Ranking - Trailing

Period FBTBX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A -3.0% 28.9% N/A
1 Yr -29.4% -24.9% 8.7% N/A
3 Yr 12.5%* -17.8% 26.7% N/A
5 Yr 20.3%* -11.9% 17.1% N/A
10 Yr 13.3%* -1.8% 18.6% N/A

* Annualized


Total Return Ranking - Calendar

Period FBTBX Return Category Return Low Category Return High Rank in Category (%)
2018 N/A -25.3% 12.3% N/A
2017 N/A -10.8% 45.8% N/A
2016 N/A -24.2% 8.7% N/A
2015 N/A -16.6% 15.2% N/A
2014 N/A -5.8% 36.7% N/A

NAV & Total Return History

FBTBX - Holdings

Concentration Analysis

FBTBX Category Low Category High FBTBX % Rank
Net Assets 2.83 B 13.9 M 44.3 B N/A
Number of Holdings 252 28 364 N/A
Net Assets in Top 10 1.26 B 7.98 M 18.8 B N/A
Weighting of Top 10 47.29% 24.8% 75.8% N/A

Top 10 Holdings

  1. Regeneron Pharmaceuticals Inc 7.15%

  2. Biogen Inc 6.91%

  3. Celgene Corp 6.70%

  4. Alexion Pharmaceuticals Inc 6.11%

  5. Gilead Sciences Inc 6.06%

  6. Biomarin Pharmaceutical Inc 4.25%

  7. Vertex Pharmaceuticals Inc 3.69%

  8. Incyte Corp 2.54%

  9. Medivation Inc 2.22%

  10. Genmab A/S 1.66%


Asset Allocation

Weighting Return Low Return High FBTBX % Rank
Stocks
99.21% 91.85% 103.20% N/A
Cash
0.75% -3.19% 5.75% N/A
Preferred Stocks
0.04% 0.00% 2.13% N/A
Other
0.00% -1.92% 2.75% N/A
Convertible Bonds
0.00% 0.00% 0.12% N/A
Bonds
0.00% 0.00% 0.94% N/A

Stock Sector Breakdown

Weighting Return Low Return High FBTBX % Rank
Healthcare
95.89% 13.80% 99.56% N/A
Financial Services
0.15% 0.00% 3.95% N/A
Utilities
0.00% 0.00% 0.00% N/A
Technology
0.00% 0.00% 61.10% N/A
Real Estate
0.00% 0.00% 1.36% N/A
Industrials
0.00% 0.00% 10.61% N/A
Energy
0.00% 0.00% 0.09% N/A
Communication Services
0.00% 0.00% 0.00% N/A
Consumer Defense
0.00% 0.00% 0.40% N/A
Consumer Cyclical
0.00% 0.00% 7.87% N/A
Basic Materials
0.00% 0.00% 0.47% N/A

Stock Geographic Breakdown

Weighting Return Low Return High FBTBX % Rank
US
93.68% 60.64% 99.56% N/A
Non US
5.53% 0.00% 38.57% N/A

FBTBX - Expenses

Operational Fees

FBTBX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.83% 0.10% 2.98% N/A
Management Fee 0.55% 0.09% 1.25% N/A
12b-1 Fee 1.00% 0.00% 1.00% N/A
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

FBTBX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load 5.00% 1.00% 5.00% N/A

Trading Fees

FBTBX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee 0.75% 0.75% 2.00% N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBTBX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 26.00% 0.00% 699.00% N/A

FBTBX - Distributions

Dividend Yield Analysis

FBTBX Category Low Category High FBTBX % Rank
Dividend Yield 0.00% 0.00% 0.01% N/A

Dividend Distribution Analysis

FBTBX Category Low Category High Category Mode
Dividend Distribution Frequency None Annually Semi-Annually Annually

Dividend Payout History


Net Income Ratio Analysis

FBTBX Category Low Category High FBTBX % Rank
Net Income Ratio -1.53% -2.15% 1.48% N/A

Capital Gain Distribution Analysis

FBTBX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Annually Annually

FBTBX - Managers

Tenure Analysis

Category Low

0.0

Category High

21.72

Category Average

10.18

Category Mode

19.09